ATE434940T1 - Verfahren zur verbesserung der immunfunktion bei säugern unter verwendung von lactobacillus reuteri-stämmen - Google Patents

Verfahren zur verbesserung der immunfunktion bei säugern unter verwendung von lactobacillus reuteri-stämmen

Info

Publication number
ATE434940T1
ATE434940T1 AT02783892T AT02783892T ATE434940T1 AT E434940 T1 ATE434940 T1 AT E434940T1 AT 02783892 T AT02783892 T AT 02783892T AT 02783892 T AT02783892 T AT 02783892T AT E434940 T1 ATE434940 T1 AT E434940T1
Authority
AT
Austria
Prior art keywords
lactobacillus reuteri
mammals
strains
immune function
improving immune
Prior art date
Application number
AT02783892T
Other languages
English (en)
Inventor
Ho-Jin Kang
Ik-Boo Kwon
Eamonn Connolly
Bo Moellstam
Dong-Seog Lee
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Application granted granted Critical
Publication of ATE434940T1 publication Critical patent/ATE434940T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT02783892T 2002-10-18 2002-10-18 Verfahren zur verbesserung der immunfunktion bei säugern unter verwendung von lactobacillus reuteri-stämmen ATE434940T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2002/001903 WO2004034808A1 (en) 2002-10-18 2002-10-18 Method of improving immune function in mammals using lactobacillus reuteri strains

Publications (1)

Publication Number Publication Date
ATE434940T1 true ATE434940T1 (de) 2009-07-15

Family

ID=32105771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02783892T ATE434940T1 (de) 2002-10-18 2002-10-18 Verfahren zur verbesserung der immunfunktion bei säugern unter verwendung von lactobacillus reuteri-stämmen

Country Status (12)

Country Link
US (1) US20060002907A1 (de)
EP (1) EP1567018B1 (de)
JP (1) JP2006506371A (de)
CN (1) CN100348119C (de)
AT (1) ATE434940T1 (de)
AU (1) AU2002347697B2 (de)
BR (1) BR0215884A (de)
DE (1) DE60232827D1 (de)
DK (1) DK1567018T3 (de)
ES (1) ES2329020T3 (de)
MX (1) MXPA05003743A (de)
WO (1) WO2004034808A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
ZA200705844B (en) * 2004-12-15 2008-09-25 Van Der Westhuzen Corne Floris Detoxifying and immunity-booster composition
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US7910127B2 (en) * 2007-03-02 2011-03-22 Biogaia Ab Use of lactic acid bacteria for improving food lysine absorption of pet animals
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
EP3139940B1 (de) * 2014-05-05 2021-02-17 Probiotical S.p.A. Zusammensetzung enthaltend l. reuteri ler03 and l. salivarius ls06 zur verwendung in der behandlung von tumoren, aids und leukämien
WO2015170159A1 (en) 2014-05-05 2015-11-12 Giovanni Mogna A composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising l. reuteri ler03 and/or l. salivarius ls06.
GB201812079D0 (en) * 2018-07-24 2018-09-05 Biogaia Ab Selection method
AU2020352646B2 (en) * 2019-09-26 2025-09-04 Precisionbiotics Group Limited Lactobacillus reuteri
AU2021380725A1 (en) * 2020-11-10 2023-07-06 Elanco Us Inc. Immunogenic probiotic compositions and methods of use including in vaccination
CN113073066B (zh) 2021-04-16 2022-01-04 段云峰 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN113881597B (zh) * 2021-10-15 2023-04-28 江南大学 一株能够提高吲哚丙烯酸以调节特异性IgE的罗伊氏乳杆菌

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139107A1 (en) * 1992-06-25 1994-01-06 Walter J. Dobrogosz Method of stimulating the immune system
DE69627994D1 (de) * 1995-12-21 2003-06-12 Biogaia Ab Stockholm Verwendung von lactobacillus reuteri zur hemmung der kryptosporidiosis in säugetieren
DE29724815U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter

Also Published As

Publication number Publication date
ES2329020T3 (es) 2009-11-20
AU2002347697A1 (en) 2004-05-04
MXPA05003743A (es) 2005-06-17
DE60232827D1 (de) 2009-08-13
DK1567018T3 (da) 2009-09-14
HK1079661A1 (en) 2006-04-13
US20060002907A1 (en) 2006-01-05
CN100348119C (zh) 2007-11-14
WO2004034808A1 (en) 2004-04-29
BR0215884A (pt) 2005-12-20
AU2002347697B2 (en) 2008-03-20
EP1567018B1 (de) 2009-07-01
JP2006506371A (ja) 2006-02-23
EP1567018A1 (de) 2005-08-31
CN1668211A (zh) 2005-09-14

Similar Documents

Publication Publication Date Title
DE60232827D1 (de) Verfahren zur verbesserung der immunfunktion bei säugern unter verwendung von lactobacillus reuteri-stämmen
EP4585264A3 (de) Menschliche cgrp-rezeptor-bindende proteine
DK1210411T3 (da) Sammensætninger og fremgangsmåder til forbedret celledyrkning
TR201816277T4 (tr) Çapraz-tür-spesifik bağlama alanı.
NZ595500A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
MY169644A (en) Use of chimeric antigen receptor-modified t cells to treat cancer
WO2005121331A8 (en) Truncated galnact2 polypeptides and nucleic acids
MX2007002528A (es) Lactobacillus plantarum con actividad reductora de grasa corporal y los alimentos que lo contienen.
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
GB0202149D0 (en) Pluripotency determining factors and uses thereof
ATE510005T1 (de) Verfahren zur isolierung von zellen aus der nabelschnur
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
WO2021262597A3 (en) Lair-1-binding agents and methods of use thereof
NZ602515A (en) Proteins that bind pi16 and uses thereof
ZA202405110B (en) Discernible cell surface protein variants of cd117 for use in cell therapy
ZA202405124B (en) Discernible cell surface protein variants of cd45 for use in cell therapy
ATE519838T1 (de) Verfahren zur herstellung von rohbakterienstämmen und deren verwendung
WO2007018671A3 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
ATE483724T1 (de) Verfahren zur erhöhung der ausbreitung von b- zellen
ATE391727T1 (de) Verfahren zur identifikation von modulatoren des humanen orexin-2-rezeptors
ATE398169T1 (de) Verfahren zur reinigung von oozysten mittels enzymatischer verdauung von faeces
ATE516349T1 (de) Verfahren zur rückfaltung von säuger- glycosyltransferasen
WO2003059932A3 (en) Methods of inducing or enhancing connective tissue repair
DE60327925D1 (de) Verwendung von löslichem fgl2 als immunosuppressivum

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1567018

Country of ref document: EP